factual

Regulator Knew of Harm and Did Not Act

Internal GlaxoSmithKline memos, leaked via a peer reviewer who faxed Nissen's manuscript to the company, revealed that GSK had already done its own meta-analysis of the unpublished data showing Rosiglitazone increased heart attacks and had shared it with the FDA, yet no regulatory decision changed—a case where the regulator had access to the full data or its meta-analysis and did not alter its stance.

factualpending

Speaker

Jacob Stegenga

Evidence Quote

“It suggested that Glaxo Smith Kline had already done their own meta-analysis based on this unpublished data. And, they'd shared that information with the FDA. And, that no regulatory decision had been made after that.”

Source

Jacob Stegenga on Medical Nihilism— EconTalk
Created: 6/13/2026, 12:09:58 AM

Your notes

Loading notes...